Brivaracetam oral/injection and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Brivaracetam oral/injection and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brivaracetam
Brand name: Briviact
Synonyms: Brivaracetam (oral/injection), Brivaracetam
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brivaracetam oral/injection-Insulin glargine, recombinant Subcutaneous
- Brivaracetam oral/injection-Insulin glulisine
- Brivaracetam oral/injection-Insulin Glulisine (Cartridges and Pens)
- Brivaracetam oral/injection-Insulin Glulisine (Vials)
- Brivaracetam oral/injection-Insulin glulisine Subcutaneous
- Brivaracetam oral/injection-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Brivaracetam Tablets
- Insulin glargine and lixisenatide Subcutaneous-Briviact
- Insulin glargine and lixisenatide Subcutaneous-Briviact (Brivaracetam Injection)
- Insulin glargine and lixisenatide Subcutaneous-Briviact (Brivaracetam Oral Solution)
- Insulin glargine and lixisenatide Subcutaneous-Briviact (Brivaracetam Tablets)
- Insulin glargine and lixisenatide Subcutaneous-Briviact Intravenous